Search results for "Highlights"


 
Results 51 - 60 of about 254 for "Highlights".

Individualizing glycemic control could reduce costs, increase quality-adjusted life-years

A cost-effectiveness analysis found that individualized control saved $13,547 per patient compared with uniform intensive control, primarily due to lower medication costs, and increased quality-adjusted life-years by 0.10.
January 2018

Cardiovascular benefits of adding ezetimibe to statin therapy may be greater in patients with diabetes, study finds

Participants were randomized to receive either ezetimibe or placebo in addition to background simvastatin, and the subgroup of patients with diabetes was compared to those without the disease.
January 2018

Risk score may help predict future glycemic control after new diagnosis of diabetes

The most important predictors of the trajectory of glucose control were body mass index and levels of HbA1c and triglycerides, according to the study of registry data from the Netherlands.
December 2017

Diabetes associated with fractures in older male veterans, with comorbidities as mediating factors

The retrospective study involved nearly 2.8 million male veterans 65 to 99 years of age, 32.3% with diabetes, who received primary care at Veterans Health Administration medical centers from 2000 to 2010.
November 2017

Insulin pumps reduced ketoacidosis, hypoglycemia in young patients with type 1 diabetes

The results provide further evidence that insulin pump therapy is safe and effective, even in routine diabetes care for unselected patients, according to the study authors.
October 2017

Cardiovascular event rates similar between once-weekly exenatide and placebo in patients with type 2 diabetes

A limitation of the industry-funded randomized trial was the high rate of early discontinuation: 43.0% of patients on exenatide and 45.2% of those on placebo.
October 2017

Rates of diabetes-related ESRD appear to decrease in U.S., Puerto Rico

From 2000 to 2014, the age-standardized incidence of end-stage renal disease (ESRD) attributed to diabetes decreased from 260.2 to 173.9 per 100,000 diabetic population.
November 2017

Type 1 diabetes associated with increased atrial fibrillation risk, particularly in women

Risk of atrial fibrillation increased with worse glycemic control and renal complications. Among patients with normoalbuminuria, researchers found no excess risk of atrial fibrillation with an HbA1c less than 9.7% for men or 8.8% for women.
September 2017

Glucose self-monitoring had no effect on glycemic control in non–insulin-treated type 2 diabetes

Although it would seem to make sense that routine glucose self-monitoring provides better outcomes, this long-held belief is not supported by the data, said an editor's note accompanying the study.
July 2017

No increase in mortality with incretin-based drugs compared to other diabetes meds, review finds

The review included 189 randomized controlled trials that compared glucagon-like peptide-1 receptor agonists or dipeptidyl peptidase-2 inhibitors with placebo or other diabetes drugs in patients with type 2 diabetes.
July 2017

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next